The immunomodulatory effects of rolipram abolish drug-resistant latent phase of Toxoplasma gondii infection in a murine model

Journal of Microscopy and Ultrastructure
Mohammed A Afifi, Mohammed W Al-Rabia

Abstract

Latent toxoplasmosis always has the risk of reactivation leading to significant sequelae. The available medications, for chronic toxoplasmosis, are awfully limited by resistance of Toxoplasma cysts. Therefore, there is a growing necessity for novel therapeutic approaches. Agents increasing cAMP levels and downregulating proinflammatory cytokine could inhibit Toxoplasma conversion to the bradyzoite stage. This study explores a potential immunomodulatory effect of rolipram, a PDE4 inhibitor, on the course of experimental toxoplasmosis and links this role to deterrence of the resistant chronic phase of the disease. Mice infected with low pathogenic strain of Toxoplasma gondii were treated with rolipram for three weeks. The effect of rolipram was evaluated through tissue injury scoring, brain cyst count, specific IgG titers as well as TNF-α, IFN-γ and IL-12 assays. Rolipram was partially able to prevent the progression to chronic toxoplasmosis. Toxoplasma brain cyst burden showed a 74% reduction while Toxoplasma-induced inflammatory foci per liver area and nucleated cells per inflammatory focus were significantly reduced: 57.14% and 61.3% respectively. Significant reduction of TNF-α (84.6%), IFN-γ (76.7%) and IL-12 (71%) levels was...Continue Reading

References

Sep 29, 2000·Progress in Nucleic Acid Research and Molecular Biology·S H FrancisJ D Corbin
Dec 19, 2000·Infection and Immunity·L A KirkmanK Kim
Feb 13, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·E BeshayG J Prud'homme
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·S-L Catherine Jin, Marco Conti
Mar 17, 2004·Trends in Pharmacological Sciences·James M O'Donnell, Han-Ting Zhang
Jun 13, 2006·Ocular Immunology and Inflammation·Holger BaatzLars-Olof Hattenbach
Feb 27, 2007·Schizophrenia Bulletin·Vern B Carruthers, Yasuhiro Suzuki
Sep 8, 2009·TheScientificWorldJournal·Tariq F Al-Shaiji, Gerald B Brock
Feb 13, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Mahesh ShivannaSangly P Srinivas
Nov 19, 2011·FEMS Microbiology Reviews·William J Sullivan, Victoria Jeffers
May 15, 2012·Pharmacological Reports : PR·Marianna SzczypkaBożena Obmińska-Mrukowicz
Apr 6, 2013·BMC Medicine·Neal KumarAlice B Gottlieb

❮ Previous
Next ❯

Citations

Feb 7, 2017·Frontiers in Microbiology·Mahbobeh MontazeriAhmad Daryani
Feb 26, 2020·Food and Waterborne Parasitology·Neda KonstantinovicFlorence Robert-Gangneux

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
phase contrast microscopy
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Zentralblatt Für Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie Und Parasitologie
H WernerJ G Meingassner
Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Yong-Hua ZhouQi Gao
Research in Veterinary Science
J K BeverleyM E Brown
Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology
Nagwa Mostafa El-SayedKhaled Fathy Elhasanein
© 2022 Meta ULC. All rights reserved